Lisa E. Porter
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Treatment and Management 6
- Diabetes Management and Research 3
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
-
- Metabolism, Diabetes, and Cancer 4
- Peroxisome Proliferator-Activated Receptors 3
- Co-authors
- Brandon Walsh (2 shared papers)Ken Wilhelm (2 shared papers)Martin I. Freed (5 shared papers)Ping Yan (1 shared paper)Jaret Malloy (1 shared paper)Carol Wysham (1 shared paper)Leigh MacConell (1 shared paper)Richard M. Bergenstal (1 shared paper)
- Journals
- Diabetes Obesity and Metabolism (1 paper)Journal of Human Hypertension (1 paper)Journal of Hypertension (1 paper)Journal of the American Society of Nephrology (1 paper)Diabetes Care (1 paper)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Lisa E. Porter
10 papers receiving 1.4k citations
Lisa E. Porter's Hit Papers
Peers
Comparison fields: 5 of 69
- Endocrinology, Diabetes and Metabolism 1.1k
- Nephrology 172
- Pharmacology 277
- Cardiology and Cardiovascular Medicine 278
- Molecular Biology 570
Countries citing papers authored by Lisa E. Porter
This map shows the geographic impact of Lisa E. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa E. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa E. Porter more than expected).
Fields of papers citing papers by Lisa E. Porter
This network shows the impact of papers produced by Lisa E. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa E. Porter. The network helps show where Lisa E. Porter may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa E. Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial Hit paper breakdown → | 2010 | 510 |
| 2 | 2010 | 282 | |
| 3 | 1999 | 224 | |
| 4 | 2003 | 201 | |
| 5 | 2006 | 85 | |
| 6 | 2005 | 52 | |
| 7 | 1998 | 49 | |
| 8 | 2004 | 47 | |
| 9 | Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study | 2003 | 1 |
| 10 | 1997 | 1 |
About Lisa E. Porter
Lisa E. Porter is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Cardiology and Cardiovascular Medicine, Nephrology and Pediatrics, Perinatology and Child Health, having authored 10 papers that have together received 1.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (6 papers), Metabolism, Diabetes, and Cancer (4 papers), Diabetes Management and Research (3 papers), Blood Pressure and Hypertension Studies (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Metabolism and Genetic Disorders (1 paper) and Renin-Angiotensin System Studies (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Nephrology (172 citations), Pharmacology (277 citations), Cardiology and Cardiovascular Medicine (278 citations) and Molecular Biology (570 citations). Lisa E. Porter has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Brandon Walsh, Ken Wilhelm, Martin I. Freed, Ping Yan, Jaret Malloy, Carol Wysham, Leigh MacConell, Richard M. Bergenstal, Mark Heise and Norman K. Hollenberg. Their work appears in journals such as Diabetes Obesity and Metabolism, Journal of Human Hypertension, Journal of Hypertension, Journal of the American Society of Nephrology and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.